Japanese pharmaceutical group Daiichi Sankyo Co said yesterday it had agreed to buy a majority stake in India’s top drug company Ranbaxy Laboratories for up to US$4.6 billion.
The deal reflects growing efforts by the world’s pharmaceutical giants to cope with fierce competition from generic drugmakers based in low-cost economies such as India.
Daiichi Sankyo said that it had entered a binding deal to acquire the stake owned by the Singh family, which controls Ranbaxy, a leading generic drug company.
It also plans to buy a 20 percent stake from public shareholders and to acquire new shares from the Indian company with the aim of taking a stake of at least 50.1 percent.
Upon completion of the transaction, which is valued at US$3.4 billion to US$4.6 billion, Ranbaxy is expected to become a subsidiary of Daiichi Sankyo.
The deal, which is subject to shareholder and regulatory approval, is expected to be completed by the end of March.
The move will “complement our strong presence in innovation with a new, strong presence in the fast growing business of non-proprietary pharmaceuticals,” Daiichi Sankyo chief executive Takashi Shoda said in a statement.
More than 90 percent of Ranbaxy’s sales come from generic products.
Ranbaxy and other, similar firms vie in the US and Europe to grab first rights to sell inexpensive generic drugs.
Under the terms of the deal, Malvinder Singh, grandson of Ranbaxy founder Bhai Mohan Singh, will continue as chief executive and also become chairman of the board of the Indian group.
“This is a significant milestone in our mission of becoming a research based international pharmaceutical company,” Malvinder Singh said in the statement.
Ranbaxy has expanded abroad by selling inexpensive copies of branded drugs off-patent and through successful challenges to patents owned by Western companies.
It has said it aims to be one of the world’s top-five generic drugmakers by 2012 with sales of US$5 billion.
The Japanese group will pay 737 rupees per share in the Indian company, a 31.4 percent premium to its closing share price on Tuesday.
MORE VISITORS: The Tourism Administration said that it is seeing positive prospects in its efforts to expand the tourism market in North America and Europe Taiwan has been ranked as the cheapest place in the world to travel to this year, based on a list recommended by NerdWallet. The San Francisco-based personal finance company said that Taiwan topped the list of 16 nations it chose for budget travelers because US tourists do not need visas and travelers can easily have a good meal for less than US$10. A bus ride in Taipei costs just under US$0.50, while subway rides start at US$0.60, the firm said, adding that public transportation in Taiwan is easy to navigate. The firm also called Taiwan a “food lover’s paradise,” citing inexpensive breakfast stalls
TRADE: A mandatory declaration of origin for manufactured goods bound for the US is to take effect on May 7 to block China from exploiting Taiwan’s trade channels All products manufactured in Taiwan and exported to the US must include a signed declaration of origin starting on May 7, the Bureau of Foreign Trade announced yesterday. US President Donald Trump on April 2 imposed a 32 percent tariff on imports from Taiwan, but one week later announced a 90-day pause on its implementation. However, a universal 10 percent tariff was immediately applied to most imports from around the world. On April 12, the Trump administration further exempted computers, smartphones and semiconductors from the new tariffs. In response, President William Lai’s (賴清德) administration has introduced a series of countermeasures to support affected
CROSS-STRAIT: The vast majority of Taiwanese support maintaining the ‘status quo,’ while concern is rising about Beijing’s influence operations More than eight out of 10 Taiwanese reject Beijing’s “one country, two systems” framework for cross-strait relations, according to a survey released by the Mainland Affairs Council (MAC) on Thursday. The MAC’s latest quarterly survey found that 84.4 percent of respondents opposed Beijing’s “one country, two systems” formula for handling cross-strait relations — a figure consistent with past polling. Over the past three years, opposition to the framework has remained high, ranging from a low of 83.6 percent in April 2023 to a peak of 89.6 percent in April last year. In the most recent poll, 82.5 percent also rejected China’s
PLUGGING HOLES: The amendments would bring the legislation in line with systems found in other countries such as Japan and the US, Legislator Chen Kuan-ting said Democratic Progressive Party (DPP) Legislator Chen Kuan-ting (陳冠廷) has proposed amending national security legislation amid a spate of espionage cases. Potential gaps in security vetting procedures for personnel with access to sensitive information prompted him to propose the amendments, which would introduce changes to Article 14 of the Classified National Security Information Protection Act (國家機密保護法), Chen said yesterday. The proposal, which aims to enhance interagency vetting procedures and reduce the risk of classified information leaks, would establish a comprehensive security clearance system in Taiwan, he said. The amendment would require character and loyalty checks for civil servants and intelligence personnel prior to
RSS